Tyber Medical, LLC is an orthopedic device manufacturer that focuses on providing rapid access to portfolio-enhancing, regulatory-approved orthopedic implants for the spine and extremity/trauma markets. Since its founding in 2012, the company has prioritized rapid product commercialization and has released 14 spine and 25 extremity/trauma systems. A key factor in Tyber Medical's success lies in its utilization of differentiated, bioengineered technology, such as TyPEEK® osteoconductive coatings and BioTy™, a new antimicrobial nano-textured surface modification to enhance its growing portfolio. The latest investment in Tyber Medical, LLC was a $225.00K grant investment received on 12 March 2019 from the National Science Foundation. With a clear focus on innovation and market access, Tyber Medical, LLC continues to make strides in the healthcare and manufacturing industries, positioning itself as a key player in providing cutting-edge orthopedic solutions. With a strong emphasis on regulatory approval, rapid product commercialization, and technology-driven enhancements, Tyber Medical, LLC presents an attractive investment opportunity for venture capitalists seeking exposure to the orthopedic medical device market.
No recent news or press coverage available for Tyber Medical, LLC.